Shandong Buchang Pharmaceuticals Co (SHSE:603858) Ending Cash Position : ¥1,012 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Shandong Buchang Pharmaceuticals Co Ending Cash Position?

Shandong Buchang Pharmaceuticals Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥1,012 Mil.

Shandong Buchang Pharmaceuticals Co's quarterly Ending Cash Position increased from Sep. 2023 (¥474 Mil) to Dec. 2023 (¥692 Mil) and increased from Dec. 2023 (¥692 Mil) to Mar. 2024 (¥1,012 Mil).

Shandong Buchang Pharmaceuticals Co's annual Ending Cash Position increased from Dec. 2021 (¥1,363 Mil) to Dec. 2022 (¥2,121 Mil) but then declined from Dec. 2022 (¥2,121 Mil) to Dec. 2023 (¥692 Mil).

Shandong Buchang Pharmaceuticals Co Ending Cash Position Historical Data

The historical data trend for Shandong Buchang Pharmaceuticals Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Buchang Pharmaceuticals Co Ending Cash Position Chart

Shandong Buchang Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

1,818.61

1,469.66

1,363.27

2,121.32

692.33

Shandong Buchang Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															1,581.66	2,476.39	473.82	692.33	1,011.77

Shandong Buchang Pharmaceuticals Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Shandong Buchang Pharmaceuticals Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2121.316	+	-1428.983
	=	692

Shandong Buchang Pharmaceuticals Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	691.586	+	320.185
	=	1,012

Shandong Buchang Pharmaceuticals Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Shandong Buchang Pharmaceuticals Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Buchang Pharmaceuticals Co (SHSE:603858) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Buchang Pharmaceuticals Co Ltd (SHSE:603858) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

No. 369, Zhonghua West Road, Shandong Province, Heze, CHN, 274000

Website

http://www.buchang.com

Shandong Buchang Pharmaceuticals Co Ltd is a pharmaceuticals company engaged in drug manufacturing. It specializes in the research and development, production and sale of Traditional Chinese patent medicines, supplemented by fields such as hi-tech industry and health industry. The company offers drugs for cardiac and cerebral vascular disease, diabetes, urinary and digestive disease, respiratory disease, gynecological disease and others. Geographically, the company holds its production bases in Shandong, Shaanxi, Hebei and Northeast China, with its marketing network spreading all over the major provinces of China.

Shandong Buchang Pharmaceuticals Co (SHSE:603858) Headlines

No Headlines